Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

25 articles from the last 30 days matching "preprint"

ResearchBIORXIVApr 2

Preprint: GEN-KnowRD: Reframing AI for Rare Disease Recognition

Researchers developed a new artificial intelligence system called GEN-KnowRD to help doctors recognize rare diseases faster and more accurately. Currently, patients with rare diseases wait years for a correct diagnosis because doctors don't have good tools to identify these uncommon conditions. This new AI system is designed to work better than previous attempts by using a smarter approach that doesn't require as much expert knowledge to keep updated.

WHY IT MATTERSFaster rare disease diagnosis could reduce the average diagnostic odyssey from years to months, allowing patients to access treatment and clinical trials earlier when interventions are most effective.
👁 Watch this spacerare diseases (general)Read →
ResearchBIORXIVMar 30

Preprint: PhenoSS: Phenotype semantic similarity-based approach for rare disease prediction and patient clustering

Researchers developed a new computer tool called PhenoSS that helps doctors diagnose rare diseases more accurately by analyzing patient symptoms in a smarter way. Instead of just matching symptoms one-by-one, this tool understands how symptoms relate to each other and accounts for differences in how different doctors record patient information. This could help patients get diagnosed faster and more correctly.

WHY IT MATTERSIf this tool becomes available in clinical practice, patients with rare diseases could receive accurate diagnoses faster by having their symptom patterns analyzed more intelligently, potentially reducing the average diagnostic odyssey timeline.
👁 Watch this spaceRead →
ResearchBIORXIVMar 30

Preprint: Interpretable Fine-tuned Large Language Models Facilitate Making Genetic Test Decisions for Rare Diseases

Researchers are testing whether artificial intelligence programs called large language models can help doctors decide which genetic tests to order for patients with rare diseases. Instead of doctors having to memorize complicated guidelines, the AI could read the patient's information and recommend whether a simple gene panel or a more complete genetic test would be best. This could make the process faster and more consistent across different hospitals.

WHY IT MATTERSIf this AI tool works well, patients with rare diseases could get the right genetic test recommended faster, potentially leading to quicker diagnoses and treatment decisions.
Good to knowRead →
ResearchBIORXIVMar 30

Preprint: Clinical, in vitro, and in vivo evidence of WAPL as a novel cohesinopathy gene and phenotypic driver of 10q22.3q23.2 genomic disorder

Scientists discovered that a gene called WAPL, which helps control how DNA is organized in cells, may cause a rare genetic disorder when it doesn't work properly. This is important because doctors previously thought only certain other genes in the same family could cause this type of disease. The researchers studied patients with this condition and did lab tests to prove WAPL is responsible for a genomic disorder affecting chromosome 10.

WHY IT MATTERSIf you or your child has developmental delays, intellectual disability, or birth defects without a genetic diagnosis, this discovery means WAPL gene testing could now identify the cause in previously undiagnosed patients.
💬 Ask your doctor10q22.3q23.2 genomic disordercohesinopathyCornelia de Lange syndromeRead →
ResearchBIORXIVMar 30

Preprint: Epigenetic Responses to Abusive versus Accidental Injuries in Children: A Cross-sectional Epigenome Wide Association Meta-analysis

Researchers studied how child abuse and accidental injuries affect DNA in different ways. They looked at saliva samples from children with injuries and used advanced technology to find specific DNA changes that appear in abused children but not in those with accidental injuries. This research could help doctors identify abuse cases earlier and understand how trauma affects children's bodies at a biological level.

WHY IT MATTERSIf validated, this epigenetic signature could provide doctors with an objective biological marker to help distinguish abuse from accidental injury in children presenting with traumatic injuries, potentially improving identification and intervention in suspected maltreatment cases.
Good to knowRead →
← PreviousPage 2 of 2

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases